• ABT-263 (Navitoclax): Mechanism, Evidence, and Workflow Inte

  2026-04-20

  ABT-263 (Navitoclax) is a potent, orally bioavailable Bcl-2 family inhibitor used in apoptosis and cancer biology research. It exhibits high affinity for Bcl-2, Bcl-xL, and Bcl-w, enabling precise interrogation of caspase-dependent apoptosis pathways. This article details its mechanism, benchmark data, and workflow best practices.

• Patient-Derived Gastric Cancer Assembloids Integrate Tumor-S

  2026-04-20

  This study introduces a gastric cancer assembloid model combining matched tumor organoids and autologous stromal cell subpopulations, offering a more physiologically relevant system for studying tumor heterogeneity and drug response. The method enhances the predictive power of preclinical drug testing and provides a platform for investigating resistance mechanisms in a patient-specific context.

• Ibuprofen in Colon Cancer Research: Protocols & Troubleshoot

  2026-04-19

  Harness the dual COX-1/COX-2 inhibition and anti-proliferative power of Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) from APExBIO for robust colon carcinoma workflows. This guide delivers advanced protocols, real-world troubleshooting, and strategic insights that elevate your apoptosis and cell cycle arrest assays.

• Phosbind Acrylamide: Precise Phosphate-Binding Reagent for S

  2026-04-18

  Phosbind Acrylamide is a specialized phosphate-binding reagent for antibody-free protein phosphorylation analysis. It enables sensitive detection of phosphorylation-dependent shifts during SDS-PAGE, facilitating studies of cellular signaling. APExBIO’s F4002 kit ensures reproducible separation of phosphorylated proteins in the 30–130 kDa range.

• In Vitro Susceptibility of Canine Staphylococci to Mupirocin

  2026-04-17

  This study provides a detailed assessment of mupirocin and novobiocin efficacy against meticillin-resistant and susceptible staphylococci in dogs, highlighting the challenges in treating canine pyoderma amidst rising antimicrobial resistance. The findings inform rational antibiotic selection for veterinary bacterial infections and underscore the need for ongoing resistance monitoring.

• Novobiocin Sodium: Applied Protocols for DNA Damage and Path

  2026-04-16

  Novobiocin Sodium, a potent aminocoumarin antibiotic, empowers researchers to dissect DNA replication, cell cycle, and metabolic pathway mechanisms with precision. This article translates recent experimental breakthroughs into actionable protocols and troubleshooting insights for advanced cell biology and antibiotic resistance studies.

• Advancing Translational Oncology: HA Peptide as a Precision

  2026-04-15

  This thought-leadership article explores how the Influenza Hemagglutinin (HA) Peptide, renowned for its role as an epitope tag, is revolutionizing protein detection and mechanistic dissection in translational oncology. Emphasizing workflow optimization, mechanistic insight, and direct application in cutting-edge cancer metastasis research, we position APExBIO’s HA tag peptide as a critical, evidence-backed tool for translational researchers.

• Optimizing Reporter Assays with EZ Cap™ Firefly Luciferase m

  2026-04-14

  Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure enhances gene regulation reporter assays and mRNA delivery studies. This article uniquely delves into mechanistic evidence, protocol nuances, and critical innovations for maximizing reporter sensitivity and reproducibility.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-04-13

  The EDTA-free Protease Inhibitor Cocktail (100X in DMSO) from APExBIO empowers protein extraction workflows that demand uncompromising integrity—especially in phosphorylation-sensitive assays. Its broad-spectrum, cation-friendly formulation delivers reliable performance in Western blotting, co-immunoprecipitation, and beyond, with clear advantages for complex sample types.

• DiscoveryProbe™ Metabolism-related Compound Library: Practic

  2026-04-12

  The DiscoveryProbe™ Metabolism-related Compound Library (SKU: L1032) addresses the need for a reproducible, well-validated collection of 493 metabolism-related compounds for advanced research. It is best suited for in vitro and ex vivo metabolic enzyme assays, pathway studies, and high-throughput screening workflows. Not intended for clinical, diagnostic, or in vivo applications.

• AMPK Regulates Mitophagy and Inflammation in Diabetic Period

  2026-04-12

  This study demonstrates that AMPK activation coordinates PINK1/Parkin-mediated mitophagy and limits NLRP3-driven inflammation in periodontal ligament fibroblasts under mechanical loading, especially in diabetic conditions. The findings highlight mitophagy as a pivotal regulator of tissue homeostasis and suggest AMPK as a potential therapeutic target for periodontal disease modulation.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody in Biomarker Assays

  2026-04-11

  The FITC Goat Anti-Rabbit IgG (H+L) Antibody accelerates sensitive detection of rabbit primary antibodies in cutting-edge immunofluorescence and flow cytometry workflows. Discover actionable protocols, troubleshooting tactics, and data-driven use cases that elevate translational biomarker discovery, as exemplified in early diabetic nephropathy research.

• Z-IETD-FMK: Optimizing Caspase-8 Inhibition in Apoptosis Res

  2026-04-11

  Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) stands out for its precise caspase-8 inhibition, enabling researchers to dissect apoptotic and immune signaling with unmatched specificity. This article details actionable workflows, troubleshooting strategies, and novel insights from recent mitochondrial apoptosis studies to empower bench scientists in immune cell and cancer model research.

• Trifluoperazine 2HCl: Dopamine D2 Receptor Inhibitor for ...

  2026-04-10

  Trifluoperazine 2HCl is a potent dopamine D2 receptor inhibitor with an IC50 of 1.1 nM, used extensively in neuropharmacology and immunology research. Its dual activity enables the study of dopaminergic signaling and macrophage-mediated ROS/autophagy, facilitating high-impact research in neuroscience and host-pathogen interactions.

• AEBSF.HCl: Advanced Strategies for Targeting Serine Prote...

  2026-04-09

  Discover how AEBSF.HCl, a broad-spectrum irreversible serine protease inhibitor, enables precision modulation of protease signaling pathways in neurodegenerative and oncological research. This article uniquely integrates new mechanistic insights and experimental strategies, offering a deeper perspective on protein cleavage inhibition for complex disease models.

452 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page